If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,125.00    -16.50 (-1.45%)
Bid:
1,124.50
Ask:
1,125.00
Spread: 0.50 (0.044%)
Market Cap: £9.51b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Transaction in Own Shares

23 May 2018 17:47

RNS Number : 0965P
Smith & Nephew Plc
23 May 2018
 

23 May 2018

Smith & Nephew plc (the "Company")

 

Transaction in Own Shares

The Company today purchased 7,080 of its Ordinary Shares of US 20¢ each through J.P. Morgan Securities plc, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 12 April 2018. These shares were issued in connection with employee share schemes in Quarter 1 2018 and have been purchased as part of a programme to reduce the Company's share capital, in order to keep it broadly constant, as announced on 15 May 2018. Details of the relevant purchase transactions are set out below:

Description of Shares:

Smith & Nephew Ordinary Shares of US 20¢ each

Number of Shares repurchased:

7,080

Average price paid per Share:

1,325.3636p

Highest price paid per Share:

1,329.0000p

Lowest price paid per Share:

1,320.0000p

Date of transaction:

23 May 2018

Broker:

J.P Morgan Securities plc

 

The Company intends to hold these shares in Treasury and then cancel them.

Following the purchase of these shares, the Company holds 15,373,257 of its shares in Treasury. The Company's issued share capital, with one voting right per share consists of 874,466,569 Ordinary Shares of US20¢ each (excluding treasury shares). This is the figure which should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

These purchases were made by J.P Morgan Securities plc on behalf of the Company and a full breakdown of the individual trades is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/0965P_-2018-5-23.pdf

This announcement is made in accordance with the requirements of LR 12.4.6 and Market Abuse Regulation 596/2014.

 

Vickie Reuben

Deputy Company Secretary

Smith & Nephew plc

Tel: 01923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSSELFMDFASELI
Date   Source Headline
8th Mar 20181:15 pmRNSDirector/PDMR Shareholding
6th Mar 20182:59 pmRNSTransaction in Own Shares
5th Mar 20184:30 pmRNSAnnual Financial Report
1st Mar 201812:29 pmRNSDirectorate Change
1st Mar 201810:54 amRNSTotal Voting Rights
27th Feb 20183:55 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSTransaction in Own Shares
14th Feb 20186:10 pmRNSTransaction in Own Shares
13th Feb 20184:11 pmRNSDirector/PDMR Shareholding
12th Feb 20189:15 amRNSTransaction in Own Shares
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018
4th Oct 20178:00 amRNSWound Expert Panel Report
2nd Oct 201710:24 amRNSTotal Voting Rights
2nd Oct 20179:00 amRNSDirectorate Change
18th Sep 20179:42 amRNSDirectorate Change
12th Sep 20174:45 pmRNSDirector/PDMR Shareholding
12th Sep 20172:18 pmRNSAdditional Listing
12th Sep 201711:30 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.